Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Somatostatin antagonists and agonists that act at the SST subtype 2 receptor

Somatostatin antagonists and agonists that act at the SST subtype 2 receptor

US Patent 6720330 · Granted Apr 13, 2004

Estimated economic value: $281,596,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Charged ion channel blockers and methods for use2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Crystalline forms of 4-ethoxy-n-(2-methoxyethyl)-n-methyl-3-(5-methyl-4-oxo-7-pr2025
Population control using engineered translocations2025
Charged ion channel blockers and methods for use2025
Charged ion channel blockers and methods for use2024
DNA sequence modification-based gene drive2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2024
DNA sequence modification-based gene drive2024
Formulated and/or co-formulated liposome compositions containing toll-like recep2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2023